Summary

Eligibility
for people ages 18-80 (full criteria)
Location
at San Francisco, California and other locations
Dates
study started
estimated completion

Description

Summary

The study is conducted to improve knowledge about the epidemiology of Lipoprotein(a) in patients with established cardiovascular disease (CVD).

Official Title

Multi-center Cross-sectional Epidemiological Study to Characterize the Prevalence and Distribution of Lipoprotein(a) Levels Among Patients With Established Cardiovascular Disease

Keywords

Cardiovascular Disease and Lipoprotein(a) CVD, Lipoprotein (a), Cardiovascular Diseases Blood draw for Lp(a)

Eligibility

You can join if…

Open to people ages 18-80

  • Signed informed consent
  • Established CVD defined as one of the following:
  • History of a myocardial infarction (MI) ≥3 months and ≤10 years before the study visit
  • History of ischemic stroke ≥ 3 months and ≤ 10 years before the study visit
  • Symptomatic PAD (intermitted claudication with ankle-brachial index ≤0.90 and/or lower limb amputation or re-vascularization due to lower limb ischemia

You CAN'T join if...

  • Patients currently enrolled in clinical studies with investigational drugs

Locations

  • Novartis Investigative Site accepting new patients
    San Francisco California 94143 United States
  • Novartis Investigative Site accepting new patients
    Fresno California 93720 United States

Details

Status
accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
Novartis Pharmaceuticals
ID
NCT03887520
Study Type
Interventional
Last Updated